跳至主要内容
临床试验/2025-524976-40-00
2025-524976-40-00招募中3 期

ECSIP : Early Corticosteroids in Severe Influenza Pneumonia, a phase III randomized controlled trial

Centre Hospital Region Metz Thionville48 个研究点 分布在 1 个国家目标入组 544 人开始时间: 2026年9月1日最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
544
试验地点
48

研究概览

简要总结

To compare the efficacy of dexamethasone versus placebo in patients with severe influenza on a hierarchical composite endpoint of all-cause mortality, number of ventilator-free days and number of ICU-free days between day 0 and day 28.

入排标准

年龄范围
18 years 至 65+ years(18-64 Years, 65+ Years)
接受健康志愿者

入选标准

  • Age ≥ 18 years
  • Admission to ICU or intermediate care for less than 2 days
  • Admission to hospital for less than 5 days
  • Diagnosis of influenza pneumonia with • PCR positive for Influenza dated less than 5 days • AND focal shadowing/infiltrates on chest X-ray or CT-scan • AND at least one of the following: cough, purulent sputum, chest pain or dyspnoea
  • Requirement of supplemental oxygen at a flow rate of at least 3 L/min OR non-invasive ventilation OR high flow oxygen therapy OR invasive mechanical ventilation.
  • Written informed or emergency consent
  • Ongoing medical insurance

排除标准

  • Moribund state
  • Patient at risk of strongyloidiasis
  • Subject with shock on enrolment and on ongoing vasopressor therapy (≥ 0.25 microg/kg/min)
  • Indication for corticosteroid therapy in a dosage above 0.5 mg/kg/day prednisone-equivalent
  • Subject deprived of liberty or under a legal protective measure (example: patients under guardianship or curatorship)
  • Pregnant or breastfeeding woman
  • Lack of clinical equipoise by the attending physician and/or the presence of a substantial risk associated with the patients’ participation in the trial.
  • Bone marrow transplant or chemotherapy-induced neutropenia
  • Known allergy to dexamethasone or to one of its excipients
  • Uncontrolled psychotic states
  • Pheochromocytoma
  • Co-infection with COVID-19
  • Cardiogenic shock secondary to influenza myocarditis
  • Known active tuberculosis or fungal infection
  • Active viral hepatitis or active herpes virus infection

研究者

发起方
Centre Hospital Region Metz Thionville
申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

LOUIS Guillaume

Scientific

Centre Hospital Region Metz Thionville

研究点 (48)

Loading locations...

相似试验